BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 15725181)

  • 1. GA2LEN--The Global Allergy and Asthma European Network.
    Frew AJ
    Clin Exp Allergy; 2005 Feb; 35(2):122-5. PubMed ID: 15725181
    [No Abstract]   [Full Text] [Related]  

  • 2. [Global Allergy and Asthma European Network (GA2LEN) addresses the epidemic of allergy and asthma].
    Panzer PC; van Cauvenberg P; Bousquet J
    Cas Lek Cesk; 2010; 149(1):32-7. PubMed ID: 20662458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GA2LEN (Global Allergy and Asthma European Network) addresses the allergy and asthma 'epidemic'.
    Bousquet J; Burney PG; Zuberbier T; Cauwenberge PV; Akdis CA; Bindslev-Jensen C; Bonini S; Fokkens WJ; Kauffmann F; Kowalski ML; Lodrup-Carlsen K; Mullol J; Nizankowska-Mogilnicka E; Papadopoulos N; Toskala E; Wickman M; Anto J; Auvergne N; Bachert C; Bousquet PJ; Brunekreef B; Canonica GW; Carlsen KH; Gjomarkaj M; Haahtela T; Howarth P; Lenzen G; Lotvall J; Radon K; Ring J; Salapatas M; Schünemann HJ; Szczecklik A; Todo-Bom A; Valovirta E; von Mutius E; Zock JP
    Allergy; 2009 Jul; 64(7):969-77. PubMed ID: 19392994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global Allergy and Asthma European Network (GA2LEN)--a focus for paediatric allergy research.
    Warner JO
    Pediatr Allergy Immunol; 2006 May; 17(3):163. PubMed ID: 16672001
    [No Abstract]   [Full Text] [Related]  

  • 5. [GA(2)LEN (Global Allergy and Asthma European Network): European network of excellence for asthma and allergic diseases].
    Gjomarkaj M; Pace E; Canonica GW; Bonini S; Ricci G; Burney P; Zuberbier T; Van Cauwenberge P; Bousquet J
    Minerva Med; 2009 Dec; 100(6):525-34. PubMed ID: 20010485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [GA2LEN (Global Allergy and Asthma European Network)].
    Bousquet J; Kauffmann F; Demoly P; Leynaert B; Bousquet PJ; Demenais F; Lenzen G; Burney PG; Zuberbier T; Van Cauwenberge P
    Rev Mal Respir; 2009 Jun; 26(6):577-86. PubMed ID: 19623103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Important questions in allergy: novel research areas.
    Bousquet J; Bieber T; Fokkens W; Kowalski ML; Humbert M; Niggemann B; Simon HU; Burney P; van Cauwenberge P; Zuberbier T; Akdis CA; Demoly P
    Allergy; 2008 Feb; 63(2):143-7. PubMed ID: 18186804
    [No Abstract]   [Full Text] [Related]  

  • 8. European birth cohort studies on asthma and atopic diseases: II. Comparison of outcomes and exposures--a GA2LEN initiative.
    Keil T; Kulig M; Simpson A; Custovic A; Wickman M; Kull I; Lødrup Carlsen KC; Carlsen KH; Smit HA; Wijga AH; Schmid S; Von Berg A; Bollrath C; Eller E; Bindslev-Jensen C; Halken S; Høst A; Heinrich J; Fantini MP; Brunekreef B; Krämer U; Willich SN; Wahn U; Lau S;
    Allergy; 2006 Sep; 61(9):1104-11. PubMed ID: 16918514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [GINA (Global Initiative for Asthma) 2006--a chapter in the bronchial asthma chronicles, or something else?].
    Tudorache V
    Pneumologia; 2007; 56(1):5-6. PubMed ID: 17491202
    [No Abstract]   [Full Text] [Related]  

  • 10. Spreading excellence in allergy and asthma: the GA2 LEN (Global Allergy and Asthma European Network) project.
    Van Cauwenberge P; Watelet JB; Van Zele T; Bousquet J; Burney P; Zuberbier T;
    Allergy; 2005 Jul; 60(7):858-64. PubMed ID: 15932373
    [No Abstract]   [Full Text] [Related]  

  • 11. [GA2LEN (Global Allergy and Asthma European Network), the perspective of the German speaking centers].
    Wöhrl S; Radon K; Ring J; Moritz K; Akdis C; Burney P; Van Cauwenberge P; Bousquet J; Zuberbier T
    Wien Klin Wochenschr; 2009; 121(17-18):589-97. PubMed ID: 19890749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cost of disease: assessing the burden to society of asthma in children in the European Union.
    van den Akker-van Marle ME; Bruil J; Detmar SB
    Allergy; 2005 Feb; 60(2):140-9. PubMed ID: 15647033
    [No Abstract]   [Full Text] [Related]  

  • 13. Building the investment case for asthma R&D: the European Asthma Research and Innovation Partnership argument.
    Walker SM; Akdis C; Dahlen SE; Djukanovic R; Edwards J; Garcia-Marcos L; Johnston S; Kupczyk M; Martin T; Myles D; Palkonen S; Papadopoulos N; Powell P; Riley J
    Clin Exp Allergy; 2016 Sep; 46(9):1136-8. PubMed ID: 27574040
    [No Abstract]   [Full Text] [Related]  

  • 14. The public health implications of asthma.
    Bousquet J; Bousquet PJ; Godard P; Daures JP
    Bull World Health Organ; 2005 Jul; 83(7):548-54. PubMed ID: 16175830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. World asthma day, 5 may 2009.
    Bissell K; Macé C
    Int J Tuberc Lung Dis; 2009 May; 13(5):546. PubMed ID: 19383182
    [No Abstract]   [Full Text] [Related]  

  • 16. Public health around the world.
    Public Health Executive Agency, European Commission and Forum for Public Health in South Eastern Europe
    J Public Health Policy; 2008 Dec; 29(4):469-73. PubMed ID: 19140297
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of VICH (Veterinary International Cooperation on Harmonisation).
    Vannier P
    Dev Biol (Basel); 2004; 119():373-5. PubMed ID: 15742648
    [No Abstract]   [Full Text] [Related]  

  • 18. [Issues related to vaccinations in the European Union].
    Slusarczyk J
    Przegl Epidemiol; 2003; 57 Suppl 1():5-8. PubMed ID: 12920998
    [No Abstract]   [Full Text] [Related]  

  • 19. A clarification on global access to drugs.
    Rys A
    Science; 2007 Feb; 315(5814):939-40. PubMed ID: 17303736
    [No Abstract]   [Full Text] [Related]  

  • 20. The costs of global warming.
    Schiermeier Q
    Nature; 2006 Jan; 439(7075):374-5. PubMed ID: 16437070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.